# Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin

> **NCT01681680** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01681680
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01681680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01681680, "Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01681680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*